[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects*; D012008:Recurrence; D013997:Time Factors
D004088:Dihydroergotoxine; D004176:Dipyridamole; D001241:Aspirin
Prévention des récidives des accidents vasculaires cérébraux ischémiques par les anti-agrégants plaquettaires. Résultats d'un essai thérapeutique contrôlé de 3 ans.